The First Affiliated Hospital of Bengbu Medical University
Bengbu, China
NCT Number: NCT07330882
Coronary artery disease (CAD) is a major chronic condition severely impacting population health in China. Our previous cohort studies revealed a high comorbidity rate between CAD and frailty, suggesting their interrelated equivalence as clinical syndromes with shared risk factors. In recent years, pilot integrated health management initiatives in China have demonstrated promising outcomes, yet evidence remains scarce regarding patients with concurrent CAD and frailty-a critical gap needing urgent resolution to achieve the "Healthy China 2030" strategic goals.
Building on prior research, this project aims to systematically evaluate existing management models for patients with CAD and frailty, develop a tailored health management framework, and implement it in clinical settings through empirical studies. The model will be optimized according to regional and demographic variations, leveraging cardiac rehabilitation centers, exercise-based interventions, and internet-enabled technologies to enhance coordinated care. By improving exercise efficacy, mitigating frailty progression, and enhancing quality of life, this initiative seeks to establish a robust chronic disease management system. The findings will provide evidence for formulating regional health policy and insurance strategies in Anhui Province, ultimately improving standardized management rates for chronic diseases.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Bengbu, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The development, application and evaluation of an innovative health management model for patients with coronary heart disease and frailty based on the "cardiac rehabilitation center" framework, exercise rehabilitation, and new technologies such as "mobile health".
Time frame: 1month,3 months, 6 months
Measuring the maximum distance within 6 minutes.
Time frame: 1month,3 months, 6 months
Quality of life was assessed using the 36-Item Short Form Health Survey questionnaire
Time frame: 1month,3 months, 6 months
The FRAIL Scale
Time frame: 1month,3 months, 6 months
Electronic grip device
Time frame: 1month,3 months, 6 months
Stopwatch
Time frame: 1month,3 months, 6 months
The short version self-reported International Physical Activity Questionnaire.
Time frame: 1month,3 months, 6 months
Calibrated electronic blood pressure monitor
Time frame: 1month,3 months, 6 months
Major Adverse Cardiovascular Events (MACE) were defined as at least one of the following: heart failure, malignant arrhythmia, recurrent angina, recurrent myocardial infarction, cardiogenic shock, cardiac arrest, or sudden cardiac death.
Time frame: 1 month, 3 months, 6 months
Changes in blood lipid biomarkers, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), were assessed.
The First Affiliated Hospital of Bengbu Medical University
Other
Health Behavior Management Program for Patients With Coronary Heart Disease: A Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07258290
Acute Coronary Syndrome, Angina Pectoris
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05599061
Arterial Occlusive Diseases, Arteriosclerosis
L'Hospitalet de Llobregat, Barcelona, Spain
View Trial DetailsNCT05027984
Arterial Occlusive Diseases, Arteriosclerosis
Pátrai, AX, Greece
View Trial DetailsNCT03253692
Arterial Occlusive Diseases, Arteriosclerosis
Lexington, Kentucky, United States
View Trial Details